VPRIV® (velaglucerase alfa for injection)
This product is licensed in the following countries:
Australia
Austria
Belgium
Brazil
Bulgaria
Canada (local website)
Cyprus
Czech Republic
Denmark (local website)
Estonia
Finland
France (local website)
Germany (local website)
Greece
Hungary
Iceland
Ireland (local website)
Israel
Italy (local website)
Latvia
Lichtenstein
Lithuania
Luxembourg
Malta
Mexico
Netherlands (local website)
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain (local website)
Sweden
Switzerland (local website)
United Kingdom (local website)
USA
For residents of the USA:
For all Shire Specialty Pharmaceuticals customer inquiries or to report an adverse experience with a specific Shire product, please call 800-828-2088.
Shire Specialty Pharmaceuticals customers may also contact us by email:
Medical Information
Please email medinfoglobal@shire.com
Customer Services
Please email CustomerService@shire.com
For all Shire Human Genetic Therapies Customer inquiries, please call OnePath SM at 866-888-0660 or contact us by email at OnePath@shire.com
Related links
Key fact
We try to find new therapies
for rare and life-threatening
diseases.
